Publications, Science content
Antibody optimization enabled by artificial intelligence predictions of binding affinity and naturalness
Deep learning-based codon optimization with large-scale synonymous variant datasets enables generalized tunable protein expression
Unlocking de novo antibody design with generative artificial intelligence
Publications
Development of ABS-101: A potential best-in-class anti-TL1A antibody for the treatment of IBD
